Document is current
Any future updates will be listed below
-
Authors
Fouani, Youssef
Kirchhof, Luisa
Stanicek, Laura
Luxán, Guillermo https://orcid.org/0000-0001-8350-8659
Heumüller, Andreas W https://orcid.org/0000-0001-7107-7257
Knau, Andrea
Fischer, Ariane
Devraj, Kavi https://orcid.org/0000-0002-5005-3413
John, David
Neumann, Philipp
Bindereif, Albrecht https://orcid.org/0000-0002-7730-7380
Boon, Reinier A https://orcid.org/0000-0001-7944-9748
Liebner, Stefan
Wittig, Ilka https://orcid.org/0000-0002-9751-8054
Mogler, Carolin https://orcid.org/0000-0003-3400-7254
Karimova, Madina
Dimmeler, Stefanie
Jaé, Nicolas https://orcid.org/0000-0002-0694-7030
-
Funding
Funding for this research was provided by:
Cardio‐Pulmonary‐Institute (390649896)
Deutsches Zentrum für Herz‐Kreislaufforschung (81X2200133)
LOEWE CePTER Epilepsy Research Center of the state Hesse
ERC Advanced Grant Angiolnc (667255)
EU HORIZON 2020 ITN (675619)
Deutsche Forschungsgemeinschaft (TRR 267)
Deutsche Forschungsgemeinschaft (SFB 1366)
Deutsche Forschungsgemeinschaft (FOR 2325)
- License Information
-
More Information
Article History
Received: 14 October 2021
Revised: 17 February 2022
Accepted: 12 April 2022
First Online: 8 May 2022
Disclosure and competing interests statement
: RAB, SD, and NJ applied for the following patent that is related to NTRAS: International PCT Patent Application No. PCT/EP2016/052246 "LONG NON‐CODING RNA FOR THE TREATMENT OF ENDOTHELIAL DYSFUNCTION". Filed 03 February 2016.
